Almost all aural cholesterol granulomas develop in the mucosa of the middle ear. We describe the case of a 14-yearold girl who presented with an asymptomatic, nontender, dark-blue, cystic lesion in the posteroinferior portion of the left ear canal. The mass was excised via a postauricular approach. Postoperatively, the mass was identifi ed as a cholesterol granuloma on pathologic examination. To the best of our knowledge, this is the fi rst reported case of a human cholesterol granuloma limited to the external ear canal.
Introduction
Cholesterol granuloma is a histopathologic term used to describe a benign mass that is formed as a result of a foreign-body reaction with the accumulation of cholesterol crystals secondary to the degradation of hemoglobin. In otology, it is not uncommon to fi nd these masses in the middle ear, mastoid, and petrous apex. We report a case of aural cholesterol granuloma in a rare location: the external ear canal.
Case report
A 14-year-old girl without any known systemic disease was referred for evaluation of an asymptomatic, nontender, dark-blue, cystic lesion in the posteroinferior portion of her left ear canal (fi gure 1). High-resolution computed tomography (CT) demonstrated a soft-tissue mass with a focal bony defect; no infi ltration was noted (fi gure 2). The neighboring air cells were well pneumatized and without fl uid accumulation.
Surgical intervention was undertaken via a postau-ricular approach. Intraoperatively, fl uid accumulation was noted between the cyst and the skin. The mass was excised completely. Postoperative pathologic examination identifi ed the mass as a cholesterol granuloma (fi gure 3). No recurrence was noted during 6 years of follow-up.
Discussion
Aural cholesterol granulomas develop almost exclusively in the mucosa of the middle ear. The nature of the clinical presentation and functional repercussions are widely variable and depend on the lesion's precise anatomic location and the involvement of nearby structures. Affected patients may present with an idiopathic blue tympanic membrane and a conductive hearing loss secondary to ankylosis of the ossicular chain, 1 retrocochlear symptoms at the level of the petrous apex, 2 or a sensorineural hearing loss in cases in which the granuloma has surrounded the endolymphatic sac. 3 A case of aural cholesterol granuloma in a dog was reported by Cox and Payne-Johnson. 4 In humans, a cholesterol granuloma with involvement of both the middle ear and the ear canal was described by Matt et al 5 in 1990, and a similar case was reported by Nikolaidis The original was the classic obstruction-vacuum theory, which was proposed by Jackler and Cho. 7 However, they realized that this hypothesis was inadequate, and they later proposed the exposed marrow theory. 7 Haginomori et al speculated that the formation of cholesterol granulomas might be related to structural changes in the eardrum. 8 Yet despite numerous experimental studies and clinical and histopathologic observations, the pathogenesis of cholesterol granuloma remains uncertain. 1, 9 We believe that it probably occurs as a result of several mechanisms. None of the aforementioned possible etiologies appears to apply to the mass in our patient. We speculate that her granuloma might have arisen as a result of a traumatic event deep to the periosteum.
In patients with an aural cholesterol granuloma, fi ndings on high-resolution CT are not specifi c. CT may demonstrate a well-defi ned, nonenhancing, expansive lesion that is isodense with brain tissue; bony defects may be variable. 2, 10 In addition to cholesteatoma, the differential diagnosis of a bony defect in the ear canal includes epidermal keratinous cyst, squamous cell carcinoma, necrotizing external otitis, eosinophilic granuloma, and keratosis obturans. A preoperative diagnosis can be made on the basis of unique fi ndings on magnetic resonance imaging (MRI). 2, 10 In our case, we did not obtain an MRI because we had not considered cholesterol granuloma in the differential diagnosis prior to surgery.
The management of cholesterol granuloma depends on its location, its behavior, its effect on nearby structures, and the patient's hearing status. In the middle ear, the management options range from simple ventilation tube insertion to a thorough mastoidectomy. 11 An infralabyrinthine or infracochlear approach has been suggested for the treatment of aggressive cholesterol granulomas of the petrous apex; for less aggressive lesions, observation with follow-up is acceptable. 2 In our case, treatment was much more straightforward than the treatment of masses located in less accessible areas. 
